Evidence map›Paper›PMID 39737348›Full record

ArticleIranian journal of microbiology2024

Evaluation of the potential of multi-trait PGPR isolates as inoculants for maize (

Ebrahim Eshaghi, Sara Mousae, Ali Hendiyani, Alireza Habibi Khave, Rahim Nosrati

Abstract read
In one paragraph

Article in Iranian journal of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ebrahim EshaghiDepartment of Plant Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Sara MousaeDepartment of Biology, Nourdanesh Institute of Higher Education, Meymeh, Iran.
Ali HendiyaniDepartment of Textile Engineering, Islamic Azad University, Science and Research Branch, Tehran, Iran.
Alireza Habibi KhaveDepartment of Organic Chemistry, Payame Noor University, Tehran, Iran.
Rahim NosratiCellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Plant growth-promoting rhizobacteria (PGPR) with a diverse set of traits can improve crop yield in agriculture. The current study aimed to evaluate the potential of multi-trait PGPR isolates as inoculants for maize Materials and Methods: In this study, 23 bacterial isolates were initially screened from maize plant rhizosphere. Ten isolates (A1-A10) were selected based on N fixation, P and K solubilization and their in vitro specific PGPR traits, such as solubilization of Zn, and Mn, the production of IAA, siderophore, ammonia, and HCN were assayed. Finally, the potential of selected isolates in enhancing the germination, height, shoot collar diameter, shoot fresh and dry weight biomass, and root dry weight of maize were evaluated. Results: Among the positive-PGPR colonies, the selected isolates demonstrated the better performance of PGPR traits such as highest nitrogen fixation, P, K, Mn, and Zn solubilization, and production of siderophore, HCN, NH3, and IAA. In addition, the maize seed germination and improvement of maize yield in a pot experiment were observed after their treatment by bacterial inoculants. Biochemical characteristics, 16S rDNA amplification, and sequencing demonstrated a high similarity of PGPR isolates to the strains of Conclusion: The findings demonstrated that these strains could prove effective PGPR inoculants for the improvement of maize crops as multiple bio-fertilizers.

Indexed as

Bio-fertilizerPlant growth regulatorsRhizobacteriaSiderophoreZea mays

Identifiers

PMID39737348
PMCPMC11682559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.